Paul, L.British Journal of DermatologyNic Dhonncha E, Clowry J, Dunphy M, Buckley C, Field S, Paul L. Treatment of severe atopic dermatitis with ustekinumab: a case series of 10 patients. Br J Dermatol 2016 [Epub ahead of print]....
The clinical efficacy of subcutaneous allergen immunotherapy (SCIT) for the treatment of patients with severe atopic dermatitis (AD) using house dust mite (HDM) extract has been reported. Cyclosporin has been regarded as an effective medication for treatment of severe AD. In this study, we investi...
The efficacy of thymopentin in the treatment of atopic dermatitis BACKGROUND: Thymopentin(TP-5) is an immunomodulatory agent which may be a promising new drug in the treatment of patients with severe atopic dermatitis. OBJECTIVE: The aim of this study was to evaluate the efficacy of thymopentin ...
Leflunomide as a novel treatment option in severe atopic dermatitis doi:10.1007/s10227-005-5010-3ATOPIC dermatitisALLERGIESDiscusses the abstract of the study "Leflunomide as a Novel Treatment Option in Severe Atopic Dermatitis," by J. Schmitt and colleagues.Journal of Cutaneous ...
Efficacy of treatment Baseline value of efficacy outcomes Outcome measures used in this study have been validated for atopic dermatitis and are recommended by HOME21. The mean baseline values for EASI, pruritus NRS, POEM, and DLQI are presented in Table2, and correspond to severe disease. ...
Omalizumab is a monoclonal antibody, targeting Fc receptor of IgE, approved for the treatment of allergic asthma and chronic spontaneous urticaria. Its utility in atopic dermatitis appears controversial from data in literature since the molecule is well tolerated but it seems less effective than other...
Epogam evening primrose oil treatment in atopic dermatitis and asthma Gamolenic acid, or gamma-linolenic acid, is a polyunsaturated fatty acid produced in the body by delta 6 -desaturase acting on linoleic acid, an essential fatty acid. It is also found naturally in oils obtained from plants,...
Meaning This study found a clinical benefit of Janus kinase inhibition in combination with TCS therapy, the mainstay treatment for AD. Abstract Importance Baricitinib, an oral selective Janus kinase 1 and 2 inhibitor, effectively reduced disease severity in moderate to severe atopic dermatitis (AD) ...
(HealthDay)—Ustekinumab is tolerated for treatment of atopic dermatitis (AD) in certain patients, according to a research letter published online Dec. 22 in the British Journal of Dermatology.
摘要: Presents information on an open, uncontrolled trial of a selected variety of evening primrose oil in severe and moderate severe atopic dermatitis conducted in 13 centres. Causes of dermatitis atopic; Patients and methodology of the study; Aim of the study; Its result....